Author:
Proskurina Anastasia S,Gvozdeva Tatiana S,Alyamkina Ekaterina A,Dolgova Evgenia V,Orishchenko Konstantin E,Nikolin Valeriy P,Popova Nelly A,Sidorov Sergey V,Chernykh Elena R,Ostanin Alexandr A,Leplina Olga Y,Dvornichenko Victoria V,Ponomarenko Dmitriy M,Soldatova Galina S,Varaksin Nikolay A,Ryabicheva Tatiana G,Zagrebelniy Stanislav N,Rogachev Vladimir A,Bogachev Sergey S,Shurdov Mikhail A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference85 articles.
1. Airley R. Cancer chemotherapy: Basic Science to the Clinic. Chichester, UK: Wiley-Blackwell; 2009. p. 342.
2. Frankfurt O, Tallman MS. Growth factors in leukemia. J Natl Compr Canc Netw. 2007;5(2):203–15.
3. Hoggatt J, Pelus LM. New G-CSF agonists for neutropenia therapy. Expert Opin Investig Drugs. 2014;23(1):21–35.
4. Weigel BJ, Rodeberg DA, Krieg AM, Blazar BR. CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. Clin Cancer Res. 2003;9:3105–14.
5. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol. 2004;4:249–58.